Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	196.22	302.08	200.35	88.5	150.56	184.5
Cash & Short-Term Investments	196.22	302.08	200.35	88.5	150.56	184.5
Cash Growth	-36.90%	50.77%	126.39%	-41.22%	-18.39%	25.37%
Accounts Receivable	10	1.42	21.09	-	-	30
Receivables	10	1.42	21.09	-	-	30
Prepaid Expenses	6.65	9.54	9.91	7.93	6.58	10.43
Other Current Assets	2.62	7.35	4.02	2.11	5.42	5.11
Total Current Assets	215.49	320.39	235.37	98.54	162.56	230.04
Property, Plant & Equipment	22.07	28	35.72	44.13	40.64	45.43
Other Long-Term Assets	3.82	3.82	3.86	3.72	3.8	3.77
Total Assets	241.38	352.21	274.95	146.39	207.01	279.24
Accounts Payable	14.49	16.26	12.84	16.92	7.28	13.8
Accrued Expenses	16.49	21.08	16.83	17.55	14.86	11.97
Current Portion of Leases	8.39	7.64	6.71	5.5	4.96	3.71
Current Unearned Revenue	46.53	65.97	150.06	31.56	37.1	91.56
Total Current Liabilities	85.9	110.95	186.44	71.52	64.2	121.04
Long-Term Leases	11.38	17.77	25.4	32.12	24.96	25.59
Long-Term Unearned Revenue	11.68	6.1	15.6	79.77	77.48	41.48
Other Long-Term Liabilities	-	-	-	0.19	-	0.47
Total Liabilities	108.96	134.82	227.45	183.6	166.64	188.59
Common Stock	1,224	1,175	935.37	802.83	749.85	694.09
Additional Paid-In Capital	174.08	156.45	129.24	119.44	87.98	71.57
Retained Earnings	-1,273	-1,122	-1,025	-967.34	-805.51	-683.27
Comprehensive Income & Other	-0.19	-0.26	-0.12	-0.03	0.18	0.39
Total Common Equity	124.55	209.52	39.63	-45.09	32.5	82.78
Shareholders' Equity	132.42	217.39	47.5	-37.22	40.37	90.65
Total Liabilities & Equity	241.38	352.21	274.95	146.39	207.01	279.24
Total Debt	19.77	25.4	32.12	37.61	29.92	29.31
Net Cash (Debt)	176.45	276.67	168.23	50.88	120.65	155.19
Net Cash Growth	-37.82%	64.46%	230.63%	-57.83%	-22.26%	35.40%
Net Cash Per Share	1.08	2.00	1.59	0.65	2.33	3.96
Filing Date Shares Outstanding	167.18	153.49	122.28	98.1	60.84	49
Total Common Shares Outstanding	160.29	153.04	119.16	86.92	59.84	48.78
Working Capital	129.59	209.44	48.93	27.02	98.36	109
Book Value Per Share	0.78	1.37	0.33	-0.52	0.54	1.70
Tangible Book Value	124.55	209.52	39.63	-45.09	32.5	82.78
Tangible Book Value Per Share	0.78	1.37	0.33	-0.52	0.54	1.70
Machinery	-	26.19	26.07	25.51	25.66	25.42
Construction In Progress	-	0.35	0.29	0.32	0.03	0.08
Leasehold Improvements	-	28.89	28.53	28.41	27.99	27.91

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q